Spatial CRISPR screening confirmed tumor-facilitating effects of immune checkpoints (PD-L1 and CD47), and also identifies tumor composition, organization, and immune infiltration in the TME, following Socs1 and TGFBR2 KO lesion. The gene discussed is TGFBR2; the disease is neoplasm.